Yahoo Web Search

Search results

1. • 

     Achieving drug-free remission in axial spondyloarthritis: Exploring the role of tight control in...

     Medical Xpress· 2 days ago

     Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in...

2. • 

     EULAR 2024 Preview: What's Not to Miss?

     Medscape· 6 days ago

     EULAR 2024 Preview: What's Not to Miss at This Year's Congress? The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of...

3. • AbbVie Inc. (NYSE:ABBV) Shares Sold by Garde Capital Inc.

     ETF DAILY NEWS· 22 hours ago

     Garde Capital Inc. lowered its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 60.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm ...

4. • AbbVie (NYSE:ABBV) Shares Up 0%

     ETF DAILY NEWS· 21 hours ago

     Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0% during mid-day trading on Thursday . The company traded as high as $166.45 and last traded at $166.15. ABBV has been the topic ...

5. • Shell Asset Management Co. Sells 9,507 Shares of AbbVie Inc. (NYSE:ABBV)

     ETF DAILY NEWS· 6 days ago

     Shell Asset Management Co. cut its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 19.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities ...

6. • Short Interest in UCB SA (OTCMKTS:UCBJY) Rises By 152.5%

     ETF DAILY NEWS· 2 days ago

     UCB SA (OTCMKTS:UCBJY – Get Free Report) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 15,400 shares, a growth of 152.5% from ...

7. • Alvotech (NASDAQ:ALVO) Short Interest Update

     ETF DAILY NEWS· 2 days ago

     Alvotech (NASDAQ:ALVO – Get Free Report) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 93,900 shares, a drop ...

8. • Amgen (NASDAQ:AMGN) Price Target Raised to $332.00 at Royal Bank of Canada

     ETF DAILY NEWS· 1 day ago

     Amgen (NASDAQ:AMGN – Free Report) had its target price hoisted by Royal Bank of Canada from $328.00 to $332.00 in a research report sent to investors on Friday, Benzinga reports. Several other ...

9. • Cresset Asset Management LLC Lowers Position in Amgen Inc. (NASDAQ:AMGN)

     ETF DAILY NEWS· 5 days ago

     Cresset Asset Management LLC cut its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities ...

10. • 

      Lichen Planopilaris: Prevalence, Treatments in the US

      Medscape· 4 days ago

      Most patients diagnosed with LPP received at least one type of medication, most commonly...